Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects

American Journal of Physiology - Endocrinology and Metabolism

Volumn 310, Issue 11, 2016, Pages E1053-E1061

  Wölnerhanssen, Bettina K ^a,b   Cajacob, Lucian ^a   Keller, Nino ^a   Doody, Alison ^c   Rehfeld, Jens F ^d   Drewe, Juergen ^a   Peterli, Ralph ^b   Beglinger, Christoph ^b   Meyer Gerspach, Anne Christin ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b St Claraspital AG   (Switzerland)

^c Diabetes Complications Research Centre   (Ireland)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Erythritol; Gastric emptying; Incretins; Sweetener; Xylitol

Indexed keywords

ACETIC ACID; CHOLECYSTOKININ; ERYTHRITOL; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; NONNUTRITIVE SWEETENER; WATER; XYLITOL; HORMONE; SWEETENING AGENT;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOATING; BREATH ANALYSIS; CARBOHYDRATE INTAKE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FASTING GLUCOSE CONCENTRATION; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; LEAN BODY WEIGHT; MALE; MAXIMUM PLASMA CONCENTRATION; NASOGASTRIC TUBE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH EMPTYING; SWEETNESS; ADULT; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECTS; INSULIN RESISTANCE; INTESTINE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLACEBO EFFECT; SECRETION (PROCESS);

ADMINISTRATION, ORAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ERYTHRITOL; FEMALE; GASTRIC EMPTYING; GLUCOSE; HORMONES; HUMANS; INSULIN RESISTANCE; INTESTINES; MALE; OBESITY; PLACEBO EFFECT; SWEETENING AGENTS; THINNESS; XYLITOL;

EID: 84983646544     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00037.2016     Document Type: Article

References (40)

1. Amo K, Arai H, Uebanso T, Fukaya M, Koganei M, Sasaki H, Yamamoto H, Taketani Y, Takeda E. Effects of xylitol on metabolic parameters and visceral fat accumulation. J Clin Biochem Nutr 49: 1–7, 2011.
2. Bandyopadhyay A, Ghoshal S, Mukherjee A. Genotoxicity testing of low-calorie sweeteners: aspartame, acesulfame-K, and saccharin. Drug Chem Toxicol 31: 447–457, 2008.
3. Bornet FR, Blayo A, Dauchy F, Slama G. Gastrointestinal response and plasma and urine determinations in human subjects given erythritol. Regul Toxicol Pharmacol 24: S296–S302, 1996.
4. Bornet FR, Blayo A, Dauchy F, Slama G. Plasma and urine kinetics of erythritol after oral ingestion by healthy humans. Regul Toxicol Pharmacol 24: S280–S285, 1996.
5. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537–543, 2004.
6. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, Staels B. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53: 890–898, 2004.
7. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 countryyears and 9·1 million participants. Lancet 377: 557–567, 2011.
8. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24: 38–48, 2000.
9. Flint N, Hamburg NM, Holbrook M, Dorsey PG, LeLeiko RM, Berger A, de Cock P, Bosscher D, Vita JA. Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study. Acta Diabetol 51: 513–516, 2014.
10. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104: 1640–1647, 1993.
11. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93: 62–66, 1978.
12. Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Metabolism of erythritol in humans: comparison with glucose and lactitol. Br J Nutr 69: 169–176, 1993.
13. Honkala S, Runnel R, Saag M, Olak J, Nommela R, Russak S, Makinen PL, Vahlberg T, Falony G, Makinen K, Honkala E. Effect of erythritol and xylitol on dental caries prevention in children. Caries Res 48: 482–490, 2014.
14. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M, Bernier M, Mosinger B, Margolskee RF, Egan JM. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 104: 15069–15074, 2007.
15. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62: 3307–3315, 2013.
16. Kishore P, Kehlenbrink S, Hu M, Zhang K, Gutierrez-Juarez R, Koppaka S, El-Maghrabi MR, Hawkins M. Xylitol prevents NEFAinduced insulin resistance in rats. Diabetologia 55: 1808–1812, 2012.
17. Knuuttila ML, Kuoksa TH, Svanberg MJ, Mattila PT, Karjalainen KM, Kolehmainen E. Effects of dietary xylitol on collagen content and glycosylation in healthy and diabetic rats. Life Sci 67: 283–290, 2000.
18. Lee A, Wils D, Zumbe A, Storey DM. The comparative gastrointestinal responses of children and adults following consumption of sweets formulated with sucrose, isomalt and lycasin HBC. Eur J Clin Nutr 56: 755–764, 2002.
19. Lifshitz F, Ament ME, Kleinman RE, Klish W, Lebenthal E, Perman J, Udall JN Jr. Role of juice carbohydrate malabsorption in chronic nonspecific diarrhea in children. J Pediatr 120: 825–829, 1992.
20. Livesey G. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 16: 163–191, 2003.
21. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 296: G735–G739, 2009.
22. Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, Daly K, Maillet EL, Ninomiya Y, Mosinger B, Shirazi-Beechey SP. T1R3 and gustducin in gut sense sugars to regulate expression of Na_-glucose cotransporter 1. Proc Natl Acad Sci USA 104: 15075–15080, 2007.
23. Mertz DP, Kaiser V, Klöpfer-Zaar M, Beisbarth H. Serumkonzentrationen verschiedener Lipide und von Harnsäure während 2-wöchiger Verabreichung von Xylit. Klin Wschr 50: 1107–1111, 1972.
24. Meyer-Gerspach AC, Wolnerhanssen B, Beglinger B, Nessenius F, Napitupulu M, Schulte FH, Steinert RE, Beglinger C. Gastric and intestinal satiation in obese and normal weight healthy people. Physiol Behav 129: 265–271, 2014.
25. Munro IC, Berndt WO, Borzelleca JF, Flamm G, Lynch BS, Kennepohl E, Bar EA, Modderman J. Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data. Food Chem Toxicol 36: 1139–1174, 1998.
26. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48: 993–999, 2008.
27. Rahman MA, Islam MS. Xylitol improves pancreatic islets morphology to ameliorate type 2 diabetes in rats: a dose response study. J Food Sci 79: H1436–H1442, 2014.
28. Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 153: 41–46, 2010.
29. Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem 44: 991–1001, 1998.
30. Rehfeld JF. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides. Acta Physiol (Oxf) 201: 405–411, 2011.
31. Rozengurt N, Wu SV, Chen MC, Huang C, Sternini C, Rozengurt E. Colocalization of the α-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol 291: G792–G802, 2006.
32. Salminen EK, Salminen SJ, Porkka L, Kwasowski P, Marks V, Koivistoinen PE. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release. Am J Clin Nutr 49: 1228–1232, 1998.
33. Salminen S, Salminen E, Marks V. The effects of xylitol on the secretion of insulin and gastric inhibitory polypeptide in man and rats. Diabetologia 22: 480–482, 1982.
34. Shafer RB, Levine AS, Marlette JM, Morley JE. Effects of xylitol on gastric emptying and food intake. Am J Clin Nutr 45: 744–747, 1987.
35. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322–1334, 2009.
36. Steinert RE, Frey F, Topfer A, Drewe J, Beglinger C. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr 105: 1320–1328, 2011.
37. Storey D, Lee A, Bornet F, Brouns F. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr 61: 349–354, 2007.
38. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514: 181–186, 2014.
39. Ventura EE, Davis JN, Goran MI. Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity (Silver Spring) 19: 868–874, 2011.
40. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, Long SJ, Morgan LM, Holst JJ, Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86: 4382–4389, 2001.